Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01760915 · ClinicalTrials.gov registry record
University of Wisconsin Severe Asthma Research Program III
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 107
- Enrollment target
NCT01760915 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 107 participants.
The verdict
NCT01760915 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 107 participants
- Enrollment target
Study Summary
The overall goal of this proposal is to better understand the basis of structural airway changes in severe asthma and how asthma exacerbations may contribute to their progression over time. The investigators propose to study a well-characterized cohort of adult and pediatric subjects with asthma using a multidisciplinary state-of-the-art approach. We hypothesize that severe asthma exacerbations, in some patients, are associated with incomplete recovery and activation of airway inflammatory cells in a regional distribution. The end result is a more permanent and less reversible airway obstruction that is a prominent feature of severe asthma.
Interventions
- OTHER NC100182 Hyperpolarized 3He
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2012-11-28 |
| Est. Completion | 2021-12-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01760915
The ClinicalTrials.gov registry entry for NCT01760915 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NC100182 Hyperpolarized 3He is the first listed.
NCT01760915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01760915 about?
NCT01760915 is a clinical study titled "University of Wisconsin Severe Asthma Research Program III". The overall goal of this proposal is to better understand the basis of structural airway changes in severe asthma and how asthma exacerbations may contribute to their progression over time. The investigators propose to study a well-characterized cohort of adult and pediatric subjects with asthma usi...
What is the current status of trial NCT01760915?
This trial is currently completed. The enrollment target is 107 participants. The study started on 2012-11-28. Estimated completion is 2021-12-17.
What interventions are being tested in trial NCT01760915?
The interventions under investigation include: NC100182 Hyperpolarized 3He (OTHER).
Who is sponsoring clinical trial NCT01760915?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.